Effect of pentoxifylline in preventing contrast-induced nephropathy
Phase 2
- Conditions
- ST elevation myocardial infarction.Acute myocardial infarction
- Registration Number
- IRCT2014092819316N1
- Lead Sponsor
- Vice chancellor for research of Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 182
Inclusion Criteria
Consent to participate; ST elevation myocardial infarction (STMI) and age over 18 years. Exclusion criteria: serum creatinine more than 1.5 mg/dl, heart failure; history of end-stage renal failure or being on dialysis; use of N-acetyl cysteine, theophylline, aminoglycosides, and nonsteroidal anti-inflammatory drugs; intravenous contrast media administration within the past two days; pulmonary edema; multiple myeloma; and uncontrolled hypertension
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum creatinine levels. Timepoint: Before angioplasty, two days after angioplasty. Method of measurement: Blood test.;Contrast-induced nephropathy. Timepoint: 48 hours after angioplasty. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method